PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 24, 1999

Primary Completion Date

June 30, 2002

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

fowlpox virus vaccine vector

BIOLOGICAL

recombinant vaccinia prostate-specific antigen vaccine

Trial Locations (10)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

15213

University of Pittsburgh Cancer Institute, Pittsburgh

19111

Fox Chase Cancer Center, Philadelphia

46202

Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis

53705

Veterans Affairs Medical Center - Madison, Madison

53792

University of Wisconsin Comprehensive Cancer Center, Madison

46202-5265

Indiana University Cancer Center, Indianapolis

02215

Beth Israel Deaconess Medical Center, Boston

08901

Cancer Institute of New Jersey, New Brunswick

37232-6838

Vanderbilt Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003871 - PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer | Biotech Hunter | Biotech Hunter